Cargando…
Evaluating the effects of design parameters on the performances of phase I trial designs
Numerous designs have been proposed for phase I clinical trials. Although studies have compared their performances, few have considered the effects of changing design parameters. In this article, we review a few popular designs, including the 3 + 3, continuous reassessment method (CRM), Bayesian opt...
Autores principales: | Zhu, Yaqian, Hwang, Wei-Ting, Li, Yimei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543020/ https://www.ncbi.nlm.nih.gov/pubmed/31193764 http://dx.doi.org/10.1016/j.conctc.2019.100379 |
Ejemplares similares
-
Design and Performance of the Phase I Upgrade of the CMS Global Trigger
por: Wittmann, Johannes, et al.
Publicado: (2016) -
Approximate Bayesian computation design for phase I clinical trials
por: Jin, Huaqing, et al.
Publicado: (2022) -
Evaluation of phase I clinical trial designs for combinational agents along with guidance based on simulation studies
por: Wang, Shu, et al.
Publicado: (2022) -
A Brief Overview of Adaptive Designs for Phase I Cancer Trials
por: Saxena, Anshul, et al.
Publicado: (2022) -
Design and Evaluation of the LAr Trigger Digitizer Board in the ATLAS Phase-I Upgrade
por: Besin, Dominique, et al.
Publicado: (2018)